Skip to main content
IMS Events Main banner

    Shaji K. Kumar, MD

    Professor of Medicine/Consultant
    Mayo Clinic, Rochester, MN, US
    Rochester, Minnesota

    Shaji K. Kumar, MD, is Consultant in the Division of Hematology and Mark and Judy Mullins Professor of Hematological Malignancies at Mayo Clinic in Rochester, Minnesota. He is the Chair of the Myeloma, Amyloidosis and Dysproteinemia Disease Group at Mayo Clinic, and Research Chair for Division of Hematology.

    Dr. Kumar received his medical degree from the All India Institute of Medical Sciences in New Delhi, India. His postdoctoral training included a residency in Internal Medicine from the All India Institute of Medical Sciences, followed by an Internal Medicine residency and a hematology/oncology fellowship at the Mayo Graduate School of Medicine in Rochester, Minnesota. He then completed a Mayo Foundation Scholar at the Dana Farber Cancer Institute in Boston.

    Dr. Kumar’s research focuses on the development of novel drugs and drug combinations for the treatment of myeloma. He is the Principal Investigator of several phase 1, 2, and 3 clinical trials. He also focuses on the mechanisms of disease progression from precursor conditions and risk stratification of plasma cell disorders. His laboratory focuses on understanding the role of bone marrow microenvironment in the development and progression of myeloma.

    Dr. Kumar serves as Chair of the NCCN Multiple Myeloma Guidelines Panel. He is the President of the International Society of Amyloidosis and the Vice- President of the International Myeloma Society. He is the current Editor in Chief of The Hematologist-American Society of Hematology’s official member newsletter.



    Disclosure information not submitted.

    Presentation(s):